Carregant...
Clinical characteristics of responders to intravitreal bevacizumab in central serous chorioretinopathy patients
PURPOSE: To investigate factors associated with good response to intravitreal bevacizumab (IVB) in central serous chorioretinopathy (CSC) patients. METHODS: We retrospectively reviewed 42 eyes of CSC patients of symptom duration more than 3 months who received a single or multiple successive IVBs on...
Guardat en:
| Publicat a: | Eye (Lond) |
|---|---|
| Autors principals: | , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Nature Publishing Group
2015
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4469674/ https://ncbi.nlm.nih.gov/pubmed/25952951 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/eye.2015.58 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|